Human papillomavirus vaccine efficacy against invasive, HPV-positive cancers: population-based follow-up of a cluster-randomised trial

Human papillomavirus vaccine efficacy against invasive, HPV-positive cancers: population-based follow-up of a cluster-randomised trial

Background Human papillomavirus (HPV) vaccination protects against HPV, a necessary risk factor for cervical cancer. We now report results from population-based follow-up of randomised cohorts that vaccination provides HPV-type-specific protection against invasive cancer.Methods Individually and/or...

Full description

Bibliographic Details
Main Authors: Joakim Dillner, Camilla Lagheden, Eero Pukkala, Tiina Eriksson, Tapio Luostarinen, Dan Apter, Matti Lehtinen, Katja Harjula, Marjo Kuortti, Johanna Palmroth, Tiina Petäjä, Pekka Nieminen, J Paavonen, Anne Bly, Penelope Gray, Kaisa Heikkilä, Mari Hokkanen, Heidi Karttunen, Mervi Nummela, Anna Soderlund-Strand, Ulla Veivo
Format: Article
Language:English
Published: BMJ Publishing Group 2021-12-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/11/12/e050669.full

Internet

https://bmjopen.bmj.com/content/11/12/e050669.full

Similar Items